Antios Therapeutics

Developer of innovative therapies to treat and cure viral diseases

placeAtlanta, Georgia, United States calendar_todayFounded 2018 groups22 employees language antiostherapeutics.com

Innovation

5 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 24 times.

YearFilings
20225
20233
20251
20261

Investor mix

23 investors on record; lead investors include GordonMD Global Investments, EPIQ, Lumira Ventures, Soleus Capital; 2 have since exited.

Investor typeCountShare
Venture capital1357%
Private equity417%
Angel & family office14%
Other / undisclosed522%
Coming soon